BOCIC(SH:601696) Xin Lang Cai Jing·2025-10-13 03:51Group 1 - The core point of the news is that Beijing Baipusi Biotechnology Co., Ltd. experienced a stock decline of 5.21%, with a current share price of 58.20 yuan and a total market capitalization of 9.769 billion yuan [1] - The company was established on July 22, 2010, and went public on October 18, 2021, focusing on providing key biological reagent products and technical services, with main revenue sources being recombinant proteins (82.27%), antibodies and other reagents (12.88%), technical services (3.04%), and others (1.80%) [1] Group 2 - According to data, a fund under Bank of China Securities holds a significant position in Baipusi, with the Bank of China Health Industry Mixed Fund (002938) owning 99,000 shares, accounting for 4.48% of the fund's net value, making it the seventh-largest holding [2] - The fund has a total scale of 158 million yuan and has achieved a year-to-date return of 46.82%, ranking 1342 out of 8234 in its category [2] Group 3 - The fund manager of the Bank of China Health Industry Mixed Fund is Li Mingwei, who has been in the position for 2 years and 235 days, with the fund's best and worst returns during his tenure being -1.21% [3]